Roche to withdraw US accelerated approval for Tecentriq to treat breast cancer

The antibody is also approved for certain types of metastatic urothelial cancer, and in PD-L1-positive metastatic triple-negative breast cancer. Credit: National Cancer Institute on Unsplash.